Key result
Elevated glucose levels significantly increased the odds of cardiovascular disease (OR 1.069, p<0.001) and endocrine diseases (OR 1.118, p<0.001) in a rural Ecuadorian population.
Why the study?
This study assessed the prevalence of metabolic syndrome and its association with cardiovascular and endocrine diseases in a rural Ecuadorian parish population.
Population
200 participants from a rural Ecuadorian parish population
Comparison
MetS biomarkers in relation to cardiovascular and endocrine disease likelihood
Design
Cross-sectional study
Authors
Loading...
MetS association with CV/endocrine risks in rural Ecuador supports screening; leaves open need for prospective confirmation.
Cross-Sectional (n=200)
Odds Ratio: 1.069
p-value: p=<0.001
Metabolic syndrome biomarkers, particularly elevated glucose, are strongly associated with cardiovascular and endocrine diseases in rural Ecuador, highlighting the need for targeted early detection and management.
Samaniego et al. (2025) conducted a cross-sectional in Metabolic syndrome (n=200). Metabolic syndrome biomarkers (glucose, cholesterol, triglycerides) was evaluated on Likelihood of cardiovascular and endocrine diseases (OR 1.069 for cardiovascular disease; OR 1.118 for endocrine disease, p=<0.001). Elevated glucose levels significantly increased the odds of cardiovascular disease (OR 1.069, p<0.001) and endocrine diseases (OR 1.118, p<0.001) in a rural Ecuadorian population.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: